79 related articles for article (PubMed ID: 20836923)
1. Antibiotic-containing biodegradable bead clusters with porous PLGA coating as controllable drug-releasing bone fillers.
Li Z; Kong W; Li X; Xu C; He Y; Gao J; Ma Z; Wang X; Zhang Y; Xing F; Li M; Liu Y
J Biomater Sci Polym Ed; 2011; 22(13):1713-31. PubMed ID: 20836923
[TBL] [Abstract][Full Text] [Related]
2. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
Shi X; Wang Y; Ren L; Huang W; Wang DA
Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
4. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
5. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
6. The degradation of the three layered nano-carbonated hydroxyapatite/collagen/PLGA composite membrane in vitro.
Liao S; Watari F; Zhu Y; Uo M; Akasaka T; Wang W; Xu G; Cui F
Dent Mater; 2007 Sep; 23(9):1120-8. PubMed ID: 17095082
[TBL] [Abstract][Full Text] [Related]
7. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin.
Xie XH; Wang XL; Zhang G; He YX; Wang XH; Liu Z; He K; Peng J; Leng Y; Qin L
Biomed Mater; 2010 Oct; 5(5):054109. PubMed ID: 20876954
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
9. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
Lee YH; Mei F; Bai MY; Zhao S; Chen DR
J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
Xu Q; Czernuszka JT
J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
[TBL] [Abstract][Full Text] [Related]
11. Transfer of apatite coating from porogens to scaffolds: uniform apatite coating within porous poly(DL-lactic-co-glycolic acid) scaffold in vitro.
Li J; Beaussart A; Chen Y; Mak AF
J Biomed Mater Res A; 2007 Jan; 80(1):226-33. PubMed ID: 17072848
[TBL] [Abstract][Full Text] [Related]
12. Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass.
Huang X; Miao X
J Biomater Appl; 2007 Apr; 21(4):351-74. PubMed ID: 16543281
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of injectable calcium sulfate bone graft material.
He Y; Gao J; Li X; Ma Z; Zhang Y; Li M; Zhang Y; Wang X; Qiu H; Liu Y
J Biomater Sci Polym Ed; 2010; 21(10):1313-30. PubMed ID: 20534187
[TBL] [Abstract][Full Text] [Related]
14. Differential loading methods for BMP-2 within injectable calcium phosphate cement.
van de Watering FC; Molkenboer-Kuenen JD; Boerman OC; van den Beucken JJ; Jansen JA
J Control Release; 2012 Dec; 164(3):283-90. PubMed ID: 22800584
[TBL] [Abstract][Full Text] [Related]
15. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres.
Félix Lanao RP; Leeuwenburgh SC; Wolke JG; Jansen JA
Acta Biomater; 2011 Sep; 7(9):3459-68. PubMed ID: 21689794
[TBL] [Abstract][Full Text] [Related]
16. PLGA/mesoporous silica hybrid structure for controlled drug release.
Xue JM; Shi M
J Control Release; 2004 Aug; 98(2):209-17. PubMed ID: 15262413
[TBL] [Abstract][Full Text] [Related]
17. Effect of lactide/glycolide monomers on release behaviors of gentamicin sulfate-loaded PLGA discs.
Yoo JY; Kim JM; Khang G; Kim MS; Cho SH; Lee HB; Kim YS
Int J Pharm; 2004 May; 276(1-2):1-9. PubMed ID: 15113609
[TBL] [Abstract][Full Text] [Related]
18. Controlled-release implant system formulated using biodegradable hemostatic gauze as scaffold.
Xu L; Wu F; Yuan W; Jin T
Int J Pharm; 2008 May; 355(1-2):249-58. PubMed ID: 18249510
[TBL] [Abstract][Full Text] [Related]
19. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
[TBL] [Abstract][Full Text] [Related]
20. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
